RecruitingPhase 2NCT05675787
Medroxyprogesterone Acetate Plus Atorvastatin in Young Women With Early Endometrial Carcinoma and Atypical Endometrial Hyperplasia
Studying Microscopic polyangiitis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Peking University People's Hospital
- Intervention
- Medroxyprogesterone acetate + Atorvastatin(drug)
- Enrollment
- 82 enrolled
- Eligibility
- 17-45 years · FEMALE
- Timeline
- 2023 – 2025
Study locations (1)
- Wang Jianliu, Beijing, Beijing Municipality, China
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05675787 on ClinicalTrials.govOther trials for Microscopic polyangiitis
Additional recruiting or active studies for the same condition.